Patients with Crohn’s disease who have high serum concentrations of Remicade may not see additional clinical benefits from combination therapy with azathioprine, according to a post hoc analysis of the SONIC trial presented during a session focused on therapeutic drug monitoring in IBD at Digestive Disease Week.
